Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | IP6K1 | Q92551 | 2/20 | 0.34 |
| ▸ | IP6K3 | Q96PC2 | 2/20 | 0.34 |
| ▸ | IP6K2 | Q9UHH9 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31301176 | 0.76 | MAPT (0.50) | KDM4EKMT2AGLAMAPTTSHR | |
| Triphenyl Phosphate SCHEMBL28761613 | 0.73 | SRC (0.64) | SRCL3MBTL1TDP1KDM4EKMT2A | |
| Triphenyl Phosphate SCHEMBL28557783 | 0.73 | SRC (0.64) | SRCL3MBTL1TDP1KDM4EKMT2A | |
| Triphenyl Phosphate SCHEMBL18116 | 0.73 | SRC (0.64) | SRCL3MBTL1TDP1KDM4EKMT2A | |
| Triphenyl Phosphate SCHEMBL483692 | 0.73 | SRC (0.64) | SRCL3MBTL1TDP1KDM4EKMT2A | |
| SCHEMBL2441052 | 0.72 | FAAH (0.42) | SRCL3MBTL1TDP1MAPTLMNA | |
| Triphenyl Phosphate SCHEMBL15815456 | 0.71 | SRC (0.61) | SRCL3MBTL1TDP1KDM4EKMT2A | |
| SCHEMBL131239 | 0.71 | CYP3A4 (0.61) | SRCL3MBTL1TDP1KDM4EKMT2A | |
| Triphenyl Phosphate SCHEMBL1924512 | 0.71 | SRC (0.61) | SRCL3MBTL1TDP1KDM4EKMT2A | |
| Triphenyl Phosphate SCHEMBL2530073 | 0.71 | SRC (0.61) | SRCL3MBTL1TDP1KDM4EKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1869063-A2 | METHODS OF MANUFACTURING BIOACTIVE 3-ESTERS OF BETULINIC ALDEHYDE AND BETULINIC ACID | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2007-12-26 | — | — | EP | claimed |
| WO-2006105356-A2 | METHODS OF MANUFACTURING BIOACTIVE 3-ESTERS OF BETULINIC ALDEHYDE AND BETULINIC ACID | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2006-10-05 | — | — | WO | claimed |
| EP-3980057-A1 | METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STXB) MONOMERS AND OLIGOMERS, AND USES THEREOF | Institut Curie (FR) | 2022-04-13 | — | — | EP | disclosed |
| WO-2020245321-A1 | METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STxB) MONOMERS AND OLIGOMERS, AND USES THEREOF | INSTITUT CURIE (FR) | 2020-12-10 | — | — | WO | disclosed |
| EP-3265109-A1 | PROCESSES FOR PREPARING PHARMACEUTICALLY RELEVANT PEPTIDES | Stealth BioTherapeutics Corp (MC) | 2018-01-10 | — | — | EP | disclosed |
| WO-2016144905-A1 | PROCESSES FOR PREPARING PHARMACEUTICALLY RELEVANT PEPTIDES | STEALTH BIOTHERAPEUTICS CORP (MC) | 2016-09-15 | — | — | WO | disclosed |
| EP-2398774-A2 | PROCESSES FOR PREPARING JAK INHIBITORS AND RELATED INTERMEDIATE COMPOUNDS | Incyte Corporation (US) | 2011-12-28 | — | — | EP | disclosed |
| WO-2010083283-A2 | PROCESSES FOR PREPARING JAK INHIBITORS AND RELATED INTERMEDIATE COMPOUNDS | INCYTE CORPORATION (US) | 2010-07-22 | — | — | WO | disclosed |
| EP-1658080-A1 | DOSING SCHEDULE FOR A ERBB2 ANTICANCER AGENTS | Pfizer Products Inc. (US) | 2006-05-24 | — | — | EP | disclosed |
| WO-2005016347-A1 | DOSING SCHEDULE FOR ERBB2 ANTICANCER AGENTS | PFIZER PRODUCTS INC. (US) | 2005-02-24 | — | — | WO | disclosed |